甲苯基氯化膦 | 5761-97-7

• 物质功能分类: 有机原料 - 有机膦化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 甲苯基氯化膦
• 中文别名: 甲基苯基磷酰氯
• 英文名称: methyl(phenyl)phosphinic chloride
• 英文别名: methylphenylphosphinic acid chloride；phenyl methyl phosphinyl chloride；Methylphenylphosphinic chloride；[chloro(methyl)phosphoryl]benzene
• CAS: 5761-97-7
• 化学式: C₇H₈ClOP
• mdl: MFCD00013902
• 分子量: 174.567
• InChiKey: BTMQENOUJJKBGT-UHFFFAOYSA-N

物化性质

• 熔点：
  36-38℃
• 沸点：
  154-156 °C (11 mmHg)
• 密度：
  1.266
• 闪点：
  >110°C
• 稳定性/保质期：
  在常温常压下保持稳定

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  8
• 危险品标志：
  C
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• 海关编码：
  29310099
• 危险品运输编号：
  UN 1760
• 包装等级：
  II
• 储存条件：
  常温、避光、存放在阴凉干燥处，并密封保存。

SDS

Name:	Methylphenylphosphinic chloride, 97% Material Safety Data Sheet
Synonym:
CAS:	5761-97-7

Section 1 - Chemical Product MSDS Name: Methylphenylphosphinic chloride, 97% Material Safety Data Sheet
Synonym:

---

SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
5761-97-7	Methylphenylphosphinic chloride	97	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

SECTION 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW Causes burns.Moisture sensitive. Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract. Inhalation may be fatal as a result of spasm, inflammation, edema of the larynx and bronchi, chemical pneumonitis and pulmonary edema. May cause burning sensation, coughing, wheezing, laryngitis, shortness of breath, headache, nausea, and vomiting.
Chronic:
Not available.

---

SECTION 4 - FIRST AID MEASURES
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

SECTION 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

SECTION 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid runoff into storm sewers and ditches which lead to waterways.

---

SECTION 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a tightly closed container. Store in a dry area. Keep refrigerated. (Store below 4C/39F.)

---

SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 5761-97-7: Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 154 - 156 deg C @ 11 mmHg
Freezing/Melting Point: 20 deg C
Autoignition Temperature: Not available.
Flash Point: > 110 deg C (> 230.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.266
Molecular Formula: C7H8ClOP
Molecular Weight: 174.57

---

SECTION 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of phosphorus, carbon dioxide, phosphoric acid.
Hazardous Polymerization: Has not been reported

---

SECTION 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 5761-97-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Methylphenylphosphinic chloride - Not listed by ACGIH, IARC, or NTP.

---

SECTION 12 - ECOLOGICAL INFORMATION Other No information available.

---

SECTION 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations.

---

SECTION 14 - TRANSPORT INFORMATION IATA
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing Group: II IMO
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing Group: II RID/ADR Not regulated as a hazardous material.

---

SECTION 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 36/37/39 Wear suitable protective clothing, gloves and eye/face protection. S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). WGK (Water Danger/Protection) CAS# 5761-97-7: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 5761-97-7 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 5761-97-7 is not listed on the TSCA inventory. It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
MSDS Creation Date: 1/16/2002 Revision #1 Date: 10/05/2004 The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  甲苯基氯化膦 在 三氯硅烷 作用下， 以 乙醚 、 苯 为溶剂， 反应 28.0h， 生成 methyl(phenyl)(o-tolyl)phosphine
  参考文献：
  名称：

  P-立体磷化合物的合成。磷化氢在 Appel 条件下的不对称氧化

  摘要：

  外消旋膦通过合成简单但理论上有趣的氧化过程以良好的对映体过量（高达 80%）和优异的产率（>95%）转化为对映体富集的氧化膦。这些氧化膦可以氧化偶联，以方便获得对映体纯的 DiPAMPO 类似物。该程序特别吸引人的方面是合成这些高价值化合物所需的操作简单和成本低。

  DOI：

  10.1021/ja072925l
• 作为产物：
  描述：

  苯基二氯化磷 在 吡啶 、 五氯化磷 作用下， 以 四氯化碳 、 正己烷 为溶剂， 反应 18.5h， 生成 甲苯基氯化膦
  参考文献：
  名称：

  P-Stereogenic N-膦基化合物的立体选择性合成

  摘要：

  由于 (R)- 和 (S)-二环己叉-D-葡萄糖甲基苯基的多样化和迄今为止尚未探索的反应性，通过简单的方法以良好的收率立体选择性地制备了许多 P-立体 N-膦基化合物次膦酸盐生成金属酰胺。在适当的条件下，获得了具有一个或两个 P-手性中心的结构不同的膦酰胺。

  DOI：

  10.1002/ejoc.201501260
• 作为试剂：
  描述：

  奈马克丁 在 哌啶 、 4-二甲氨基吡啶 、 水 、 碳酸氢钠 、 甲苯基氯化膦 、 三乙胺 作用下， 以 甲醇 、 乙醇 、 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 8.0h， 生成 莫西菌素
  参考文献：
  名称：

  莫西菌素中间体及制备方法、莫西菌素的制备方法

  摘要：

  本发明公开了一种莫西菌素中间体及制备方法、莫西菌素制备方法。该莫西菌素中间体的制备方法包括如下步骤：尼莫克汀与β‑苯基丙烯酰氯进行亲核取代反应，反应结束后，经后处理，即得所示莫西菌素中间体。本发明提供的莫西菌素中间体的制备方法，通过采用β‑苯基丙烯酰氯作为羟基的保护试剂，反应结束后，经后处理(柱层析)纯化，得到所述莫西菌素中间体的纯度达98％以上，产率达到92％以上，而且成本低、反应时间短，适于大规模工业化安全生产。

  公开号：

  CN114591347A

文献信息

• [EN] 5-MEMBERED AND BICYCLIC HETEROCYCLIC AMIDES AS INHIBITORS OF ROCK<br/>[FR] AMIDES HÉTÉROCYCLIQUES À 5 CHAÎNONS ET BICYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE ROCK
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2019014308A1

  公开（公告）日：2019-01-17

  The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

  本发明提供了化合物的结构式（I）：或其立体异构体、互变异构体或药学上可接受的盐，其中所有变量如本文所定义。这些化合物是选择性ROCK抑制剂。本发明还涉及包含这些化合物的药物组合物以及使用它们治疗心血管、平滑肌、肿瘤学、神经病理学、自身免疫、纤维化和/或炎症性疾病的方法。
• Novel organophosphorus derivatives of indazoles and use thereof as medicinal products
  申请人：Cherrier Marie-Pierre

  公开号：US20050137171A1

  公开（公告）日：2005-06-23

  The present invention relates in particular to novel chemical compounds, particularly to novel organophosphorus derivatives of indazoles, to the compositions containing them, and to the use thereof as medicinal products for treating cancers.

  本发明特别涉及新型化合物，特别是吲唑的新型有机磷衍生物，包含它们的组合物，以及将其用作治疗癌症的药物产品。
• Photolysis of some unsymmetrical phosphinic azides in methanol
  作者：Martin J.P. Harger、Sally Westlake

  DOI：10.1016/0040-4020(82)80195-6

  日期：1982.1

  less bulky. For t-butylmethylphosphic azide there is very little preference for migration of But relative to Me. Small amounts of unrearranged products such as ButPhP(O)NHOMe and ButPhP(O)NH2 are generally produced in the photolyses, together with the methyl phosphinates RPhP(O)OMe (major product when R = Me) resulting from (non-photochemical) solvolysis of the azide.

  当alkylphenylphosphinic酸PRHP（O）N 3（R =甲基，乙基，镨我，或卜吨）在MeOH中光解任一烷基或苯基可以从P到N的Curtius重状重排迁移。产品的组成表明，烷基R的迁移是优选的。但是，该偏好并不大，并且随着R改变Bu t →Pr i →Et→Me（相对于Ph的大约迁移能力分别为2.1、1.7、1.3和1.2）而降低，这可能是因为PhP键具有更好的能力当R的体积较小时，可以假设Ph迁移具有正确的构象。对于叔丁基甲基叠氮化物，Bu t的迁移非常少。相对于我。少量未重排的产物如卜吨PHP（O）NHOMe和卜吨PHP（O）NH 2，一般在photolyses产生，连同甲基膦酸盐RPHP（O）OME（主要产物，当R = Me）的从所得（非光化学）叠氮化物的溶剂分解。
• P-Stereogenic Phosphorus Compounds: Effect of Aryl Substituents on the Oxidation of Arylmethylphenylphosphanes under Asymmetric Appel Conditions
  作者：Kamalraj V. Rajendran、Lorna Kennedy、Declan G. Gilheany

  DOI：10.1002/ejoc.201000733

  日期：2010.10

  The effects of aryl ring substitution on the dynamic resolution of aryl(methyl)phenylphosphanes under asymmetric Appel reaction conditions have been studied. As expected, substitution at the ortho position strongly affects the degree ofstereoselection that can be achieved. Unexpectedly, however, there was no variation of stereoselectivity with the electronic nature of the para substituents, which suggests

  研究了在不对称 Appel 反应条件下芳环取代对芳基（甲基）苯基膦动态拆分的影响。正如预期的那样，邻位取代强烈影响可以实现的立体选择的程度。然而，出乎意料的是，立体选择性没有随对位取代基的电子性质而变化，这表明存在两个选择过程。在通往所需叔膦底物的路线上，在芳基苯基氯化膦中观察到了一个不寻常的卤素交换过程。
• Resolution of Chiral Phosphate, Phosphonate, and Phosphinate Esters by an Enantioselective Enzyme Library
  作者：Charity Nowlan、Yingchun Li、Johannes C. Hermann、Timothy Evans、Joseph Carpenter、Eman Ghanem、Brian K. Shoichet、Frank M. Raushel

  DOI：10.1021/ja0658618

  日期：2006.12.1

  phosphotriesterase and 15 mutant enzymes. For each substrate, the leaving group was 4-hydroxyacetophenone while the other two groups attached to the phosphorus core consisted of an asymmetric mixture of methyl, methoxy, ethyl, ethoxy, isopropoxy, phenyl, phenoxy, cyclohexyl, and cyclohexoxy substituents. For the wild-type enzyme, the relative rates of hydrolysis for the two enantiomers ranged from 3 to 5.4 x 10(5)

  一系列 16 个手性磷酸酯、膦酸酯和次膦酸酯的对映体对用于确定细菌磷酸三酯酶和 15 种突变酶内固有的立体选择性歧视的广度。对于每种底物，离去基团是 4-羟基苯乙酮，而与磷核相连的其他两个基团由甲基、甲氧基、乙基、乙氧基、异丙氧基、苯基、苯氧基、环己基和环己氧基取代基的不对称混合物组成。对于野生型酶，两种对映异构体的相对水解速率范围为 3 到 5.4 x 10(5)。使用活性位点内的位点特异性突变的各种组合来创建修饰酶，其对映选择性特性发生改变。对于单点突变酶 G60A，立体选择性相对于野生型酶提高了 1-3 个数量级。获得了额外的突变体，其中对于本研究测试的 16 对对映异构体中的 13 对，立体选择性与野生型酶相反。最引人注目的例子是 4-乙酰苯基甲基苯基磷酸酯的水解。G60A 突变体优先水解 SP 对映异构体的因子为 3.7 x 10(5)。I106G/F132G/H257Y 突变体以